Dr. Haigentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-2465
Summary
- I am a medical oncologist with expertise in the design and conduct of innovative clinical trials to improve the lives of cancer patients. I recently joined the Rutgers Cancer Institute of New Jersey as the Chief of Thoracic Medical Oncology and of Head and Neck Medical Oncology, and as Clinical Director of Integration for the Oncology Service Line at RWJBarnabas Health.
Dedicated to outstanding clinical care, research excellence, and commitment to medical education.
Clinical Expertise
- Lung cancer, Head and neck cancer, Clinical research
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1999 - 2001- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 1999
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1995 - 1998- Rutgers New Jersey Medical SchoolClass of 1995
Certifications & Licensure
NJ State Medical License 1996 - 2025
NY State Medical License 1998 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2005 Jun 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsHIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune Biomarkers Impacting Lung Cancer Screening and Management.Ayse Ece Cali Daylan, Catarina Martins Maia, Shirin Attarian, Xiaoling Guo, Mindy Ginsberg
Clinical Lung Cancer. 2024-03-01 - 1 citationsPhase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-...Missak Haigentz Jr, Jeannette Y Lee, Elizabeth Y Chiao, David M Aboulafia, Lee Ratner
Clinical Cancer Research. 2023-12-15 - 1 citationsLocally Advanced Lung Cancer.Sarah Oh, George N Botros, Milan Patel, Missak Haigentz, Eshan Patel
Hematology/oncology Clinics of North America. 2023-06-01
Press Mentions
Accelerating Access to Breakthrough Cancer TherapiesFebruary 9th, 2020
New Jersey’s First National Cancer Institute Community Oncology Research Program (NCORP) Awarded to Atlantic Health Cancer ConsortiumAugust 22nd, 2019
Shop TalkAugust 10th, 2017- Join now to see all
Grant Support
- The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP); National Community Oncology Research Program (NCORP) - Community SitesNational Cancer Institute (NCI)2019–2025
Committees
- Member, Conquer Cancer Foundation of ASCO, YIA Grants Selection Committee 2015 - 2018
- President, New York Head and Neck Society 2014 - 2015
Professional Memberships
- Member
- Member
Other Languages
- Armenian, Spanish
External Links
- Information for Patientshttps://cinj.org/missak-haigentz-jr-md
- Einstein Faculty Profilehttp://www.einstein.yu.edu/faculty/8566/missak-haigentz/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
